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Amphiphilic peroxynitrite decomposition catalysts in liposomal 
assemblies 
Julianne A Hunt, Jinbo Lee and John T Groves 
Background: Peroxynitrite (ONOO-), a toxic biological oxidant, has been 
implicated in many pathophysiological conditions. The water-soluble 
porphyrins 5,10,15,20-tetrakis(N-methyl-4’-pyridyl)porphinato iron(lll) 
(FeTMPyP) and manganese(lll) (MnTMPyP) have recently emerged as potential 
drugs for ONOO- detoxification, and FeTMPyP has demonstrated activity in 
models of ONOO- related disease states. We set out to develop amphiphilic 
analogs of FeTMPyP and MnTMPyP suitable for liposomal delivery in sterically 
stabilized liposomes (SLs). 
Results: Three amphiphilic iron porphyrins (termed la-c) and three man- 
ganese porphyrins (termed 2a-c) bound to liposomes and catalyzed the 
decomposition of ONOO- The polyethylene-glycol-linked metalloporphyrins 1 b 
and 2b proved the most effective of these catalysts, rapidly decomposing 
ONOO- with second-order rate constants (k,,,) of 2.9 x 1 O5 M-l s-j and 
5.0 x 1 O5 M-l s-l, respectively, in dimyristoylphosphatidylcholine liposomes. 
Catalysts 1 b and 2b also bound to SLs, and these metalloporphyrin-SL con- 
structs efficiently catalyzed ONOO-decomposition (k,,, = 2 x 1 O5 M-l s-1). The 
analogous metalloporphyrins la and 2a, which are not separated from the 
vesicle membrane surface by polyethylene glycol linkers, were significantly less 
effective (k,,= 3.5 x 1 O4 M-1 s-l). 
Conclusions: For these amphiphilic analogs of FeTMPyP and MnTMPyP, the 
polarity of the environment of the metalloporphyrin headgroup is intimately 
related to the efficiency of the catalyst; a polar aqueous environment is essential 
for effective catalysis of ONOO- decomposition. Thus, catalysts 1 b and 2b 
react rapidly with ONOO- and are potential therapeutic agents that, unlike their 
water-soluble TMF’yP analogs, could be administered as liposomal formulations 
in SLs. These SL-bound amphiphilic metalloporphyrins may prove to be highly 
effective in the exploration and treatment of ONOO- related disease states. 
Introduction 
Peroxynitrite (ONOO-) is a potent oxidant formed by the 
direct and rapid combination of nitric oxide and the super- 
oxide anion (O,-•) [l-3]. ONOO- crosses lipid membranes 
at a rate significantly faster than the rates of its known 
decomposition pathways [4], indicating that this oxidant, 
unlike reactive radicals such as O,-• or HO*, can travel dis- 
tances of cellular dimensions. Thus, even in the presence of 
biological membranes, ONOO- should have free access to 
cell interiors. ONOO- is known to nitrate tyrosine residues 
in proteins [5,6], and to oxidize metalloenzymes [7,8], DNA 
[9,10], lipids [ll], sulfhydryls [12] and methionines [13]. In 
light of this reactivity, ONOO- has been implicated in a 
host of disease states, including neurodegenerative disor- 
ders such as Alzheimer’s disease [13-171, amyotrophic 
lateral sclerosis [18-211, stroke [Z-24], AIDS dementia [25] 
and Huntington’s disease [26]; heart diseases such as ather- 
osclerosis [27]; chronic inflammation and autoimmune dis- 
eases such as arthritis [ZB], inflammatory bowel disease 
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[29,30] and acute respiratory disease syndrome [31]; and 
cancer [32-341, ischemia-reperfusion injury [1,35,36], septic 
shock [37] and chronic rejection of renal allografts [38]. 
This large and growing body of evidence for the major 
role of ONOO- in a wide variety of human diseases has 
naturally led to a search for drugs that can detoxify the 
powerful oxidant, and a family of synthetic, water- 
soluble porphyrins has emerged as potential candidates 
[39-411. Stern and co-workers [40] discovered that the 
iron porphyrins 5,10,15,20-tetrakis(N-methyl-4’-pyridyl)- 
porphinatoiron(II1) (FeTMPyP) and 5,10,15,20-tetrakis 
(2,4,6-trimethyl-3,5-sulfonatophenyl)porphinatoiron(III) 
(FeTMPS) catalyze the efficient decomposition of 
ONOO- to NO,- under physiological conditions. These 
iron porphyrins have profound activity in biological 
models of ONOO- related disease states and have been 
investigated as therapeutic agents for diseases in which 
ONOO- has been implicated [40,42,43]. 
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We have shown that ONOO- reacts rapidly and stoichio- 
metrically with the water-soluble synthetic manganese 
porphyrin 5,10,15,20-tetrakis(N-methyl-4’-pyridyl)porphi- 
nato manganese(II1) (MnTMPyP) to generate oxoman- 
ganese intermediates [39,44]. Further, MnTMPyP 
catalyzed the rapid reduction of ONOO- in the presence 
of common biological reducing agents such as ascorbate, 
Trolox@ (a water-soluble analog of a-tocopherol), and glu- 
tathione (Figure 1) [45]. In addition to this ‘peroxynitrite 
reductase’ activity, MnTMPyP has previously been shown 
to possess significant superoxide dismutase (SOD) activity 
in vitro and to protect cells from oxidative stress; however, 
it is significant that the scavenging of O,-• alone could not 
fully explain the cell-protective effects of MnTMPyP in a 
SOD-null strain of Eschetichia coli [46]. Finally, the syn- 
thetic manganese porphyrin .5,10,15,20-tetrakis(4-benzoic 
acid)porphinato manganese(II1) (MnTBAP) has demon- 
strated pharmacological efficacy in ONOO- related 
disease models [41,47]. In combination, these experi- 
ments point to the potential use of MnTMPyP and related 
manganese complexes for pharmaceutical intervention in 
pathological processes related to both Oz-*and ONOO-. 
In light of the therapeutic possibilities of FeTMPyP, 
MnTMPyP and related metal complexes, we have sought 
to design amphiphilic analogs of these water-soluble met- 
alloporphyrins that would retain catalytic activity when 
Figure 1 
NO,* 
/N+g 
H3C 
k3 e-, H+ 
/ 
Mn(lll)TMPyP 
ONOO- 
Chemistrv & Bioloav 
Reduction of ONOO- by MnTMPyP. Rate constants: k, = 1.8 x 106 
M-l s-’ ; k2 = 0.018 s-l ; ks= 5.4 x 1 O7 M-1 s-l for ascorbate; 
ks= 1.3 x 1 O5 M-l S’ for glutathione; ks= 7.0 x 10” M-1 s-1 for Trolox@. 
placed in phospholipid vesicular assemblies [48]. Lipo- 
somes are attractive vehicles for the delivery of 
chemotherapeutic agents: the drugs can be encapsulated 
in the aqueous interior volumes or incorporated in the 
lipid membranes of the liposomes and transported to 
target cells without the need for covalent bonding 
between the drug and the targeting ligand. During trans- 
port, liposomes can protect the incorporated drug from 
metabolic degradation while protecting non-target cells 
from the drug [49]. The recent development of sterically 
stabilized liposomes with enhanced biological stability has 
revitalized the prospects for the use of liposomes as drug 
carriers; these liposomes avoid rapid uptake by the phago- 
cytic molecules of the reticuloendothelial system (primar- 
ily the liver and spleen) and thus have long blood 
circulation times [SO-521. 
We report herein the development of new membrane- 
bound metalloporphyrin catalysts of ONOO- decomposi- 
tion that are amenable to liposomal drug delivery, and we 
have demonstrated the compatibility of these catalytic 
systems with sterically stabilized liposomes. 
Results and discussion 
Design strategies 
We sought to develop a vesicle-bound agent for the cat- 
alytic decomposition of ONOO- in order to exploit the 
advantages of liposomal drug-delivery systems. Thus, we 
set out to design an amphiphilic or hydrophobic metallo- 
porphyrin-based catalyst which could reasonably be 
expected to react rapidly with ONOO-. Because the rates 
of reaction of the metalloTMPyPs with ONOO- 
(-2 x lo6 M-Is-l) are among the highest known for this 
oxidant [39,40,44], we anticipated that amphiphilic 
analogs of TMPyP, such as FeAmPEGTPyP (lb) and 
MnAmPEGTPyP (Zb; Figure Z), would be excellent 
choices for porphyrin-based, membrane-bound ONOO- 
decomposition catalysts. 
The first step in our design strategy, however, was to evalu- 
ate extant membrane-binding metalloporphyrins for cat- 
alytic ONOO- decomposition activity. Several families of 
membrane-associated metalloporphyrins for the construc- 
tion of self-assembling, multicomponent membrane ensem- 
bles have been described previously, and these constructs 
have demonstrated various forms of catalytic and electron- 
transfer activity [48,53,54]. Figure 3 shows a few of these 
porphyrins, including 5,10,15,20-tetrakis(2,4,6-trimethyl- 
phenyl)porphinatoiron (III) (FeTMP), a,B,a,B-meso-[tetra- 
(o-3P-hydroxy-5-cholenylamidophenyl]porphinatoiron(III) 
(FeChP), and 5,10,15-meso-[tris(p-carboxyphenyl))-ZO-(octa- 
decylphenyl)]-porphinatoiron(II1) (FeTCAmP). Phospho- 
lipid vesicles, which form the membrane-mimetic matrix 
for the assembly of these porphyrins into multicomponent 
systems, can be divided into a number of discrete regions 
distinguished by their polarity (e.g., the aqueous interior 
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Figure 2 
Amphiphilic polyethylene glycol-3 (PEG-3)- 
linked ONOO- decomposition catalysts. The 
lipophilic dodecyl ‘legs’ of the molecule 
anchor it in one leaflet of the membrane 
bilayer, while the hydrophilic PEG-3 linkers 
allow the positively charged porphyrin 
macrocycle to extend into the external 
aqueous solvent. The pink ball in the center of 
the porphyrin macrocycle represents the 
bound metal, Fe in compound 1 b or Mn in 
compound 2b. 
volume, the hydrophobic membrane bilayer, the outer 
hydration sphere and the aqueous bulk solvent) [55]; 
therefore, vesicles allow for assembly of components on 
the basis of their polarity. The three iron porphyrins 
shown in Figure 3 are thus localized by their polarity in 
specific regions of the vesicle bilayers: the tetramesityl 
porphyrin FeTMP is located in the hydrophobic interior 
of the vesicle; the steroidal porphyrin FeChP [.53] spans 
the bilayer membrane as shown, with the metallopor- 
phyrin macrocycle located in the middle of the bilayer; 
and the amphiphilic tricarboxy porphyrin FeTCAmP 
[48,56] is anchored in the membrane by its single 
lipophilic tail, with its metalloporphyrin headgroup 
located at the surface of the membrane, at the interface 
between the membrane and the bulk aqueous solvent. 
These three membrane-bound iron porphyrins were evalu- 
ated for catalytic ONOO- decomposition activity, but the 
presence of these compounds did not affect the rate of 
ONOO- decay; only spontaneous decay of peroxynitrite 
was observed [57]. That is, none of these porphyrins proved 
to be efficient ONOO- decomposition catalysts. The 
hydrophobic environment of FeChP and FeTMP is most 
likely to be responsible for the slow rates of reaction of 
these compounds with the hydrophilic ONOO-, but the 
lack of catalytic activity of the amphiphilic porphyrin 
FeTCAmP was more puzzling. Examination of the catalytic 
activity of 5,10,15,20-tetrakis(4-benzoic acid)porphine 
(TBAP), however, which is the water-soluble ‘parent’ of 
the amphiphilic FeTCAmP, proved that the parent por- 
phyrin catalyzes ONOO- decomposition at a surprisingly 
slow rate (k,,,= 5 x 104M-‘s-r; data not shown). Although 
this rate precludes the porphyrin from demonstrating effi- 
cient catalytic activity at low concentrations, it is consistent 
with the observations by Szabo and coworkers [47] that 
MnTBAP is an effective scavenger of ONOO- at high 
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Figure 3 
CH 
Chemistry & Biology 
Membrane-associated iron porphyrins. FeTMP 
is located in the hydrophobic interior of the 
vesicle, FeTCAmP is anchored in the 
membrane by a lipophilic tail, with the 
metalloporphyrin headgroup located in the 
interface between the membrane and the 
aqueous solvent, and FeChP spans the 
membrane bilayer, with the metalloporphyrin 
macrocycle located in the middle of the bilayer. 
concentrations. Given the slow reaction of its parent por- 
phyrin with ONOO-, FeTCAmP would not be expected to 
show significant catalytic ONOO- decomposition activity. 
Finally, we turned to the preparation of amphiphilic 
analogs of the fast ONOO- decomposition catalysts 
FeTMPyP and MnTMPyP, armed with the knowledge 
that the best candidates for amphiphilic ONOO- decom- 
position catalysts would reside in a hydrophilic environ- 
ment. As depicted in Figure 2, we envisaged that, in 
liposomal preparations, the highly charged tetrapyri- 
dinium porphyrin macrocycles of these amphiphilic com- 
pounds would reside at the interface between the lipid 
membrane and the bulk aqueous solution, while the four 
lipophilic sidechains would be firmly anchored in the 
hydrophobic bilayer. 
Although metalloporphyrins la and 2a (see Figures 4 and 
5 for the structures of all six amphiphilic TMPyP analogs), 
with their simple dodecyl sidechains, proved the easiest 
amphiphilic TMPyP analogs to synthesize and character- 
ize, our expectation that a hydrophilic environment for the 
metalloporphyrin headgroup would prove to be necessary 
for the efficiency of the catalysts prompted us to prepare 
the polyethylene glycol (PEG)-linked porphyrins lb-c 
and Zb-c. The PEG linkers of compounds lb-c and 2b-c 
were added to extend the porphyrin headgroup further 
out of the interfacial region between the membrane and 
the external solution and further into the bulk solvent. We 
found that the hydrophilicity of the environment of the 
porphyrin headgroup correlated very well with the effi- 
ciency of the catalysts: the rate of ONOO- decomposition 
catalyzed by the PEG-linked metalloporphyrins was an 
order of magnitude faster than the rate of ONOO- decom- 
position catalyzed by the metalloporphyrins with simple 
dodecyl chains. This remarkable discrepancy in the activ- 
ity of these structurally similar catalysts demonstrated that 
incorporation of the PEG linkers was indeed essential for 
the successful design of effective ONOO- decomposition 
catalysts; at low catalyst concentrations (-1OpM) the 
simple tetradodecylpyridinium metalloporphyrins did not 
significantly increase the rate of ONOO- decomposition, 
while the PEG-linked metalloporphyrins at the same con- 
centrations enhanced the rate of ONOO- decomposition 
at least tenfold. 
Synthesis of the amphiphilic catalysts and preparation of 
vesicles 
The pyridinium porphyrins 6a-c used in these studies were 
synthesized, as shown in Figure 4, by peralkylation of 
5,10,15,20-tetrakis(4-pyridyl)porphine (TPyP, 5) with the 
appropriate alkyl iodide [58]: dodecyl iodide is commer- 
cially available, while iodides 4a and 4b were prepared by 
direct iodination [59] of the corresponding commercially 
available alcohols 3a and 3b. HzAmTPyP (Q), with four 
simple dodecyl sidechains, was prepared from TPyP in 90% 
yield; HaAmPEGTPyP (6b), with the four dodecyl 
sidechains attached to the porphyrin macrocycle via PEG-3 
spacers, was prepared in 94% yield; and HaAmPEG,TPyP 
(6c), with the dodecyl sidechains attached to the porphyrin 
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Figure 4 
Synthesis of amphiphilic tetrapyridinium 
porphyrins from tetrapyridylporphine (5) and 
alkyl iodides. CI zb5 -0 
I*, imidazole, Ph,P 
toluene, A 
- C,z”z, -0 
3a: n=2 4a: n=2 (80%) 
3b: t-1=5 4b: n=5 (66%) 
5 (TPyP) 
RI =C,,H,,I (90%) 
RI = 4a (94%) 
RI = 4b (73%) 6a (H,AmTPyP): R =C,,H,, 
6b (H,AmPEGTPyP): R = C,pH25-o+‘) 
6c (H,AmPEG,TPyP): R=C,2H25-O++j 
Chemistry & Biology 
macrocycle via PEG-6 spacers, was prepared in 73% yield. 
The three amphiphilic iron porphyrins la-c and three 
amphiphilic manganese porphyrins Za-c were then pre- 
pared in good yields from the corresponding amphiphilic 
free bases 6a-c by metallation of the porphyrin macrocy- 
cles under standard conditions [53], as shown in Figure 5. 
With the six amphiphilic porphyrins in hand, we prepared 
suspensions of small unilamellar vesicles doped with the 
porphyrins la-c and Za-c by sonication of thin films of 
lipid-porphyrin mixtures in phosphate buffer, as we have 
described previously [48,53]. Similarly, vesicular suspen- 
sions doped with the porphyrins 2a-c and a-tocopherol 
were prepared by sonication of thin films of lipid-por- 
phyrin-tocopherol mixtures in buffer. For experiments 
requiring ascorbate, vesicles were incubated with ascorbate 
Figure 5 
for 30 min prior to using the vesicular suspensions, in order 
to allow the ascorbate to diffuse through the lipid mem- 
branes and into the interior aqueous compartments of the 
vesicles [60]. Finally, sterically stabilized small unilamellar 
vesicles doped with porphyrin lb or porphyrin 2b plus a- 
tocopherol were prepared by the same protocol, from thin 
films containing -60 mol% dimyristoylphosphatidylcholine 
(DMPC), 30mol% cholesterol and 5 mol% PEG-2000- 
dipalmitoylphosphatidylethanolamine (PEG-ZOOO-DSPE). 
Peroxynitrite decomposition by the iron porphyrins 
We determined the rates of ONOO- decomposition cat- 
alyzed by vesicular suspensions of the amphiphilic iron 
porphyrins la-c using stopped-flow spectrophotometry. 
We have previously shown that phospholipid vesicles are 
not disrupted under the conditions of the stopped-flow 
Metallation of amphiphilic free-base 
porphyrins 6a-c to provide iron porphyrins 
la-c and manganese porphyrins 2a-c. 
la (FeAmTPyP): 82% 
1 b (FeAmPEGTPyP): 94% 
lc (FeAmPEG,TPyP): 91% 
6a (H,AmTPyP) 
6b (H,AmPEGTPyP) 
6c (H,AmPEG,TPyP) \ 
Mn(OAc),, 2,6-lutidine 
THF-MeOH, A 
2a (MnAmTPyP): 95% 
2b (MnAmPEGTPyP): 89% 
2c (MnAmPEG,TPyP): 82% 
Chemistry & Biology 
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experiments [4]. The catalytic rate constants were mea- 
sured by monitoring the disappearance of the strong 
ONOO- absorbance at 302 nm. Figure 6a shows typical 
traces for the decomposition of ONOO- in the absence of 
any porphyrin, with a self-decay rate constant 
kself= 0.26 s-l (trace i), and for the decomposition of 
ONOO- in the presence of iron porphyrins la (trace ii), lb 
(trace iii) and lc (trace iv). 
Figure 6 
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Typical kinetic profiles of the reactions of vesicular suspensions of iron 
porphyrins la-c with ONOO-. (a) Decomposition of ONOO- moni- 
tored at 302 nm, in the absence of porphyrin (trace i); and in the pres- 
ence of 2.6 pM FeAmTPyP (la; trace ii); 2.5 uM FeAmPEGTPyP (1 b, 
trace iii); and 3 FM FeAmPEGsTPyP (ic, trace iv). The full scale corre- 
sponds to 0.8 OD. The background absorption due to porphyrin results 
in vertical displacement of traces (ii), (iii) and (iv) relative to (i). The posi- 
tion of trace (ii) reflects this normal vertical displacement, while traces 
(iii) and (iv) have been additionally offset for convenience. (b) Linear 
least-squares fitting of the pseudo-first order rates of decomposition of 
ONOO- (kobs) versus FeAmPEGTPyP (1 b) concentration. Each data 
point is the mean of 3-5 trials. Extrapolation of the line gives an inter- 
cept of 0.24 s-l, which is consistent with the rate of self-decomposition 
of ONOO- under these conditions. The second-order rate constant, 
given by the slope of the line, is 2.9 x 1 O5 M-l s-t (R= 0.99819). 
The rate constants (k,,,) for the decomposition of ONOO- 
catalyzed by the amphiphilic iron porphyrins la-c are 
shown in Table 1. These rate constants were determined 
via a series of stopped-flow kinetic experiments in which 
the initial ONOO- concentrations were held constant at 
100 PM and the porphyrin concentrations were varied over a 
range of -0.5 to 20 PM. As shown for FeAmPEGTPyP (lb) 
in Figure 6b, a plot of the pseudo-first-order rate constants 
(kobs) so obtained versus catalyst concentrations provided 
the apparent first-order rates of ONOO- decomposition 
(k,,,) catalyzed by each of the three porphyrins. 
Significantly, insertion of the PEG spacers in compounds 
lb and lc resulted in a large increase in the rate of ONOO- 
decomposition, as compared to the rate of decomposition 
catalyzed by FeAmTPyP. FeAmTPyP (la), with its simple 
dodecyl sidechains, is a much less effective catalyst than 
either FeAmPEGTPyP (lb) or FeAmPEG,TPyP (1~). 
Also, while insertion of the PEG-3 spacer in FeAmPEGT- 
PyP resulted in a dramatic increase in the rate of ONOO- 
decomposition, extension of the spacer to six PEGS in 
FeAmPEG,TPyP offered no further increase in rate. 
Clearly the catalyst functions more effectively when attach- 
ment of the PEG-3 linker enables it to extend out into the 
interface region between the vesicle surface and the bulk 
aqueous solution, but no further gain in catalytic efficiency 
is observed when the linker is doubled in length. We 
observed an analogous trend in catalytic efficiency versus 
linker composition in the manganese porphyrins Za-c (see 
below). Finally, it should be noted that, although the k,,, 
of the PEG-6-linked porphyrin lc was nearly identical to 
the k,,, of the PEG-3-linked analog lb, the PEG-6 por- 
phyrin lc strongly promoted vesicle aggregation, making 
this catalyst less manageable than its PEG-3 analog lb. 
Peroxynitrite reduction by the manganese porphyrins 
The oxidation of MnTMPyP by ONOO- is fast 
(k, = 1.8~ 106M%-r), producing oxoMn(IV)TMPyP and 
NO,* (see Figure l), but Mn(II1) porphyrins are poor cata- 
lysts for ONOO- decomposition because the first-order 
reduction of the oxoMn(IV) species back to the Mn(II1) 
oxidation state is slow (k,). However, we have recently 
demonstrated that MnTMPyP can catalyze the rapid 
reduction of ONOO- in the presence of biological reducing 
agents such as ascorbate (k,,, = 2.2 x lo6 M-%-i), glutathione 
(k,,, = 3.2 x 106M-ls-r), and Trolox@, a water-soluble analog 
of a-tocopherol (k,,, = 1.1 x lo6 M-‘s-1) [45]. These agents 
rapidly reduce oxoMn(IV)TMPyP back to MnTMPyP (k3), 
efficiently closing the catalytic cycle. We thus expected 
that the manganese analogs of the amphiphilic iron 
porphyrins la-c described above would become active 
catalysts in the presence of biological reducing agents. 
The rates of ONOO- reduction in the presence of vesicu- 
lar suspensions of the amphiphilic manganese porphyrins 
Za-c were determined by monitoring the disappearance 
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Table 1 
ONOO- decomposition catalysts. 
Porphyrin Fe catalyst 
TMPyP FeTMPyP 
TMPyP 
TMPS FeTMPS 
AmPEGTPyP lb 
AmPEGTPyP 1 b/ascorbate 
AmPEGTPyP 1 b/SLs* 
AmPEG,TPyP lc 
AmTPyP la 
k,,, (M-’ s-‘) 
2.2 x 1 oe* 
6.5 x 1 05* 
2.9 x 105 
3.3 x 105 
2.3 x 1 O5 
2.0 x 105 
4.0 x 104 
Mn catalyst Reductant 
MnTMPyP Ascorbate 
MnTMPyP Trolox@ 
2b Ascorbate 
2b a-Tocopherol 
2b/SLs* a-Tocopherol 
2c Ascorbate 
2a Ascorbate 
kcai (M-l s-‘) 
2.2x10”’ 
1.1 x lo”+ 
5.0 x 105 
4.6 x 105 
1.9x 105 
1.6 x 105 
3.3 x 104 
*From [39]; +from 1451; *SLs, sterically stabilized liposomes. 
of ONOO- at 302 nm by stopped-flow spectrophotome- 1.5 equivalents of ascorbate per equivalent of ONOO-. 
try. As with MnTMPyP, the manganese porphyrins 2a-c Although ascorbate alone did participate in reduction of 
showed poor catalytic activity in the absence of reducing ONOO-, the second-order rate of this process was slow 
agents: Figure 7a shows typical traces for the decomposi- (k, = 236M-is-l) (see also [61,62]) compared to the por- 
tion of ONOO- in the absence (trace i) of any porphyrin, phyrin-catalyzed reduction. In a separate experiment, we 
and in the presence of Mn(III)AmPEGTPyP (2b, trace also measured the rate of ONOO- decomposition cat- 
ii). While the presence of the porphyrin does decrease alyzed by FeAmPEGTPyP (lb) plus ascorbate, but we 
the half-life of ONOO- somewhat, the rate of ONOO- found no significant rate acceleration for the iron catalyst 
reduction catalyzed by 2b is limited by the rate of reduc- in the presence of this biological reducing agent (see 
tion of oxoMn(IV)AmPEGTPyP back to the Mn(II1) Table 1). Clearly, the function of ascorbate in the man- 
state, and is therefore much slower than the rate of ganese amphiporphyrin-catalyzed ONOO- reduction is 
ONOO- decomposition catalyzed by the analogous iron the rapid reduction of the amphiphilic oxoMn(IV) species 
porphyrin lb. to the corresponding Mn(II1) amphiporphyrins. 
However, the second-order rate of reaction of Mn(III)- 
AmPEGTPyP (2b) with ONOO- to provide oxoMn(IV)- 
AmPEGTPyP (measured by monitoring the disappearance 
of Mn(III)AmPEGTPyP at 462nm or the concurrent 
appearance of oxoMn(IV) at 434 nm, as shown in Figure 7b) 
showed that the oxidation of 2b compared well with the 
rate of ONOO- decomposition catalyzed by the analogous 
iron porphyrin lb: k, = 3.6~ 105M-rs-1 for 2b, while 
k,,, = 2.9 x LO5 M-‘s-1 for lb. Thus, we expected that por- 
phyrins 2a-c would efficiently catalyze the decomposition 
of ONOO- in the presence of the appropriate agents for 
rapidly reducing the amphiphilic oxoMn(IV) porphyrins to 
the corresponding Mn(II1) porphyrins. 
In the presence of ascorbate, the amphiphilic manganese 
porphyrins 2a-c showed significant catalytic activity; in 
fact, the rates of ONOO- reduction catalyzed by the man- 
ganese porphyrins under these reducing conditions com- 
pared well with the rates of ONOO- decomposition 
catalyzed by the iron porphyrins (see Table 1). Figure 8a 
shows typical traces for the disappearance of ONOO- in 
the absence of any porphyrin (trace i), in the presence of 
ascorbate only (trace ii), and in the presence of manganese 
porphyrins 2a (trace iii), 2b (trace iv), and 2c (trace v) plus 
As with the iron porphyrins la-c, MnAmPEGTPyP (2b) 
and MnAmPEG,TPyP (2c) are much more effective pta- 
lysts than MnAmTPyP (2a). The manganese porphyrins 
thus showed the same trend in catalytic efficiency versus 
linker composition that we observed for the iron porphyrins; 
that is, insertion of the PEG-3 spacer in MnAmPEGTPyP 
greatly increased the rate of catalytic ONOO- reduction, as 
compared to the rate of reduction catalyzed by MnAmTPyP, 
but insertion of the PEG-6 spacer in MnAmPEGbTPyP 
offered no further increase in rate. This analogous behav- 
ior of the amphiphilic iron and manganese porphyrins cor- 
roborates our conclusion that these catalysts function most 
effectively when allowed to extend into the interface 
region between the vesicle surface and the bulk aqueous 
solution. As with the iron porphyrin lc, the manganese 
porphyrin 2c strongly promoted vesicle aggregation. 
Remarkably, a-tocopherol also proved to be an excellent 
reducing agent for the oxomanganese(IV) amphiphilic por- 
phyrins. In our previous experiments with the water-soluble 
MnTMPyP, we found that Trolox@, a water-soluble analog 
of a-tocopherol, rapidly reduced oxoMn(IV)TMPyP to 
Mn(III)TMPyP (k, = 7.0 x lo6 M-‘s-l). However, the lipid- 
soluble a-tocopherol (delivered as a vesicular suspension) 
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Typical kinetic profiles of the reaction of a vesicular suspension of 
MnAmPEGTPyP (2b) with ONOO-. (a) Trace (i) shows the 
decomposition of ONOO- (100 PM), monitored at 302 nm, in the 
absence of porphyrin 2b, and trace (ii) shows the decomposition of 
ONOO- (100 FM), monitored at 302 nm, in the presence of 2.5 pM 
2b. (b) Trace (i) shows the disappearance of Mn(lll)AmPEGTPyP 
(7.5 FM) in the presence of ONOO- (100 PM), monitored at 462 nm, 
and trace (ii) shows the appearance of dxoMn(IV)AmPEGTPyP 
(7.5 pM) in the presence of ONOO- (100 yM), monitored at 434 nm. 
The full scale corresponds to 0.5 OD. 
Y 
was completely ineffective as a reducing agent [45]. Nev- 
ertheless, as shown in Figure 8b, upon co-incorporation of 
a-tocopherol in phospholipid vesicles with MnAmPEGT- 
PyP (Zb), the decomposition of ONOO- was just as fast in 
the presence of a-tocopherol (k,,, = 4.6 x IO5 M-‘s-r) as in 
the presence of ascorbate (k,,, = 5.0 x lo5 M-ls-r). 
This porphyrin-tocopherol-lipid assembly, depicted in 
Figure 9, can be compared to redox-active membrane 
ensembles that we have designed previously [48,53,54]. 
For example, in a model vesicular system for biocompati- 
ble catalysis, electron transfer from a membrane-associ- 
ated enzyme to the steroidal porphyrin MnChP (the iron 
analog of this porphyrin, FeChP, is shown in Figure 3) was 
(a) 1 
2c + ascorbate + ONOO- 
2b f ascorbate + ONOO- 
A302 
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Chemistry&Biology 
Typical kinetic profiles of the reactions of vesicular suspensions of 
manganese porphyrins 2a-c with ONOO-. (a) Decomposition of 
ONOO- (100 FM) monitored at 302 nm: in phosphate buffer (trace i, 
self-decay); in the presence of ascorbate (150 PM, trace ii); and in the 
presence of ascorbate (150 PM) plus 3.0 uM MnAmTPyP (2a, trace 
iii); 3.0 f.rM MnAmPEGTPyP (2b, trace iv); and 3.0 FM 
MnAmPEGsTPyP (2c trace v). The full scale corresponds to 0.6 OD. 
The background absorption due to porphyrin or ascorbate results in 
vertical displacement of traces (ii), (iii), (iv) and (v) relative to (i); all 
traces have been additionally offset for convenience. (b) Trace (i) 
shows the decomposition of ONOO- (75 PM) in phosphate buffer 
(self-decay); trace (ii) shows the reduction of ONOO- (75 pM) in the 
presence of a-tocopherol (83.5 PM); and trace (iii) shows the 
reduction of ONOO- (75 PM) in the presence of a-tocopherol 
(83.5 PM) plus 3.2 PM MnAmPEGTPyP (2b). All traces are monitored 
at 302 nm. The full scale corresponds to 0.4 OD. The background 
absorption due to porphyrin or tocopherol results in vertical 
displacement of traces (ii) and (iii) relative to (i). The position of trace 
(iii) reflects this normal vertical displacement, while trace (ii) has been 
additionally offset for convenience. 
mediated by an amphiphilic flavin which served as an 
electron shuttle [54]. In a multi-heme system for the 
exploration of membrane-associated electron transfer, 
electrons traveled through a ternary construct consisting of 
a cytochrome c recruited to the membffine surface by 
interaction with an amphiphilic tricarboxy Zn porphyrin 
(similar to FeTCAmP, shown in Figure 3) that was, in 
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Figure 9 
MnAmPEGTPyP (2b) and a-tocopherol 
(shown in blue) self-assemble in phospholipid 
vesicles to form an ordered system for the 
catalytic reduction of ONOO-. The water- 
soluble ONOO- reacts with the amphiphilic 
manganese(lll) porphyrin to produce the 
oxomanganese(lV) porphyrin and NO,*; the 
lipid-soluble biological reductant then transfers 
an electron to the oxoMn(lV) species, 
converting it back to the Mn(lll) oxidation state 
and thus closing the catalytic cycle. 
NO,- + NO,- 
“‘\ 1 e- 
Chemistry & Biology 
turn, tethered to a membrane-embedded MnChP [48,63]. 
In the present multicomponent catalytic assembly 
(Figure 9), the aqueous oxidant ONOO- is detoxified when 
it gives up its oxidizing equivalents to the membrane- 
bound amphiphilic manganese(II1) porphyrin, producing 
the oxoMn(IV) porphyrin and NO,*; the catalytic cycle is 
closed when the lipid-soluble a-tocopherol transfers an 
electron to the oxoMn(IV) species and thus converts it back 
to the Mn(III) oxidation state. 
Peroxynitrite decomposition by metalloporphyrins bound 
to sterically stabilized liposomes 
The amphiphilic metalloporphyrins FeAmPEGTPyP (lb), 
and MnAmPEGTPyP (Zb) plus a-tocopherol bind to steri- 
tally stabilized liposomes (SLs), and these porphyrins1 
constructs efficiently catalyze the decomposition of 
ONOO-. We measured the rates of ONOO- decomposi- 
tion catalyzed by these porphyrin-S1 constructs by moni- 
toring the disappearance of ONOO- at 30’2 nm using 
stopped-flow spectrophotometry, as described above. We 
found that the lb-SL construct catalyzed ONOO- de- 
composition with a rate as rapid as the rate of ONOO- 
decomposition catalyzed by lb bound to DMPC vesicles, 
and that the Zb-a-tocopherol-SL construct catalyzed 
ONOO- reduction at a slightly, but not significantly, 
slower rate than the comparable Zb-a-tocopherol-DMPC 
system (see Table 1). 
SLs are much more stable in biological environments than 
conventional phospholipid vesicles because SL formula- 
tions include phosphatidylethanolamine lipids covalently 
attached to long PEG chains. The enhanced stability of 
SLs has been attributed to the steric barrier presented to 
biological macromolecules by the flexible and highly 
mobile PEG chains [50]. The development of SLs has 
greatly improved the prospects for the use of liposomes in 
medicine [50,51]. SLs show reduced uptake by the liver 
and spleen and increased uptake by the gut, bone marrow 
and, particularly, the skin and carcass [64]. 
More significantly, because of their increased blood circu- 
lation time, SLs naturally extravasate to tissues where the 
vasculature is inherently ‘leaky’, resulting in accumulation 
of SLs at sites of tumors and inflammation [65]. SL-based 
cancer chemotherapy, by far the most prevalent medical 
application of SLs, has relied on the natural accumulation 
of these liposomes in tumor tissues both to deliver toxic 
anticancer agents, such as doxorubicin, directly to the 
tumors, and to protect other organs from the toxic effects 
of the drugs [66]. This passive targeting approach can also 
be applied to sites of inflammation and infection, in which 
the local vascular permeability is increased by the body 
itself, as part of the repair process [67]. Finally, SLs have 
recently proved amenable to active, site-specific targeting 
when the targeting ligands are attached to the tips of the 
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lipid-conjugated PEG molecules [68-701. Thus, we antici- 
pate that lb-SL and Zb-a-tocopherol-SL could be deliv- 
ered to sites of ONOO- toxicity and could therefore show 
activity in a variety of ONOO- related diseases. 
Summary 
We have designed three amphiphilic iron porphyrins la-c 
and three amphiphilic manganese porphyrins Za-c that 
bind to liposomes and catalyze the decomposition of 
ONOO-; the catalytic rates of these compounds are sum- 
marized in Table 1. Although the tetradodecyl pyridinium 
metalloporphyrins la and 2a are not particularly good cata- 
lysts, the PEG-3-linked porphyrins lb and Zb, as well as 
the PEG-6-linked porphyrins lc and Zc, are more effec- 
tive by an order of magnitude. Similarly, the analogous 
water-soluble porphyrins FeTMPyP and MnTMPyP are 
more effective by an order of magnitude than the PEG- 
substituted porphyrins lb-c and Zb-c. We conclude that 
this family of ONOO- decomposition catalysts performs 
most effectively when dissolved in aqueous solution, 
quite well at the interface of the lipid membrane and the 
bulk solution (as in compounds lb-c and Zb-c), and rather 
poorly when tied to the surface of the lipid membrane (as 
in compounds la and Za). 
As potential ,therapeutic agents, these amphiphilic PEG- 
substituted metalloporphyrins have an important advan- 
tage over their water-soluble TMPyP analogs: they bind to 
phospholipid vesicles and thus can be administered as lipo- 
somal formulations. Liposomal delivery of the amphiphilic 
manganese catalysts will also allow co-delivery of these 
compounds with the required reducing agent, thus circum- 
venting any possibility that the manganese porphyrins 
might be inaccessible in viva to biological reducing agents 
such as ascorbate, glutathione and tocopherol. 
Because of the promise that sterically stabilized liposomes 
have shown in a variety of biomedical applications [50-521, 
we have measured the rates of ONOO- decomposition by 
our best catalysts (lb and Zb/a-tocopherol) in sterically sta- 
bilized liposomes as well as in conventional liposomes, and 
we concluded that these SL-bound amphiphilic porphyrins 
effectively catalyzed the rapid decomposition of ONOO- 
(see Table 1). Delivery of the amphiporphyrins in SLs may 
allow these drugs to circumvent potential toxicity prob- 
lems, as SLs avoid rapid uptake by the liver and naturally 
extravasate to tumors [65] and areas of inflammation [67], 
both of which are potential sites of ONOO- activity 
[28-341. Thus, in light of recent demonstrations that water- 
soluble porphyrins FeTMPyP [40,42] and MnTBAP 
[41,47] show activity in biological models of ONOO-- 
related disease states, we anticipate that our new SL- 
bound amphiphilic ONOO- decomposition catalysts may 
prove to be highly effective in the chemotherapeutic treat- 
ment of any or all of the host of disease states in which 
ONOO- has been implicated. 
Significance 
Peroxynitrite (ONOO-) is a potent biological oxidant 
that has been implicated in a large and growing array of 
human diseases, and there is clearly a need for drugs 
that can detoxify ONOO-, both for further exploration 
and for treatment of ONOO- related diseases. We 
designed the amphiphilic metalloporphyrins FeAm- 
PEGTPyP (lb) and MnAmPEGTPyP (2b) as mem- 
brane-binding analogs of known water-soluble ONOO- 
decomposition catalysts, and we have shown here that 
both compounds have significant catalytic activity in the 
decomposition of ONOO-. The related amphiporphyrins 
MAmTPyP and MAmPEG,TPyP (where M represents 
either Fe or Mn) allowed us to explore the reactivity of 
ONOO- in environments of varying polarity. 
We have also demonstrated that the amphiphilic nature 
of metalloporphyrins lb and 2b renders them amenable 
to delivery as liposomal formulations in sterically stabi- 
lized liposomes (SLs). SLs have been shown to deliver 
incorporated drugs to sites of inflammation and tumor; 
these liposomes can also be targeted to specific tissues 
with the addition of targeting ligands. In addition, SL 
delivery of drugs can potentially protect the body from 
toxic side effects of the drugs by reducing nonspecific 
uptake by the liver and spleen. Thus, the amphipor- 
phyrin-SL constructs described here may afford power- 
ful and flexible new strategies for the exploration and 
treatment of ONOO- related disease states. 
Materials and methods 
Materials 
Tetrapyridylporphine, sodium ascorbate, tocopherol and cholesterol 
were purchased from Aldrich; polyoxyethylene-3-lauryl ether (3a), 
polyoxyethylene-6-lauryl ether (3b), and DMPC were purchased from 
Sigma; and PEG-2000-DSPE was purchased from Shearwater 
Polymers, Inc. Water used in synthetic work-up procedures was dis- 
tilled; water used in all other experiments was distilled and deionized 
(Millipore, Milli-0). 
Analytical thin-layer chromatography (TLC) was performed using plates 
coated with a 0.25 mm thickness of silica gel, either with (for the 
iodides) or without (for the porphyrins) PF254 indicator (Analtech); 
plates were visualized with ultraviolet (UV) light, iodine or p-anisalde- 
hyde stain. Gel-filtration chromatography was performed with 
Sephadex LH-20 (Pharmacia) or Sepharose 4B (Sigma). 
Nuclear magnetic resonance (NMR) spectra were measured at 
500 MHz on a Varian VXR500. Chemical shifts for 1 H NMR spectra are 
reported in 6 units to 0.01 ppm precision with coupling constants 
reported in Hz to 0.1 Hz precision. Residual chloroform (6 7.26) and 
DMSO (6 2.50) were used as internal references for spectra measured 
in these solvents. For 13C NMR spectra, residual chloroform (6 77.0) 
and DMSO (6 39.5) were used as internal standards. High-resolution 
and fast atom bombardment (FAB) mass spectra were measured on a 
Kratos MS50 mass spectrometer at the Princeton University Mass 
Spectrometry Facility, and electrospray mass spectra were measured 
on a Hewlett-Packard 5989B MS Engine. UV-visible absorbance 
spectra were recorded on a Hewlett-Packard HP8452A spectropho- 
tometer. Fluorescence spectra were recorded on a Perkin-Elmer 
MPF66 fluorimeter. Elemental analyses were performed by Robertson 
Laboratories, Florham Park, NJ. 
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Synthesis of amphiphilic porphyrins 
The amphiphilic porphyrins 6a-c were prepared according to the 
method of Calvin et al. [58], by alkylation of TPyP (5) with an excess of 
the appropriate alkyl iodide. Representative procedures for the synthe- 
sis of alkyl iodide 4a and for the synthesis of porphyrin 6b from TPyP 
and 4a are described below. 
As noted by Meunier et al. [71,72], cationic porphyrins are difficult to 
characterize by standard methods, as their poor combustion properties 
often lead to large errors in elemental analyses, and their lack of volatil- 
ity makes them unsuitable for FAB mass spectrometry. Electrospray 
mass spectrometry (ES-MS) was shown to be the best method for the 
characterization of tri- and tetracationic porphyrins. In addition to the 
above-mentioned difficulties, the alkylated pyridyl porphyrins 6a-c 
demonstrated a pronounced tendency to aggregate in a wide variety of 
solvents, leading to complex ‘H and 13C NMR spectra. For the tetrado- 
decylpyridinium porphyrin 6a, this aggregation problem was amelio- 
rated by heating the sample to 15O”C, at which temperature the peaks 
in the ‘H NMR spectrum were clearly resolved; however, even at 
15O”C, the PEG-substituted porphyrins 6b and 6c showed complex 
NMR spectra. Hence, although we present the ‘H NMR data for these 
compounds below, we have relied on ES-MS for the complete charac- 
terization of compounds 6a-c (see Table 2). Our tetracationic por- 
phyrins show characteristic [711 m/4, m-H+/3, and m-R+/3 peaks 
(where R is the alkyl sidechain of the alkylpyridinium group), with the m- 
H+/3 most abundant for the tetradodecylpyridinium porphyrin 6a, and 
the m-R+/3 peak most abundant for the PEG-substituted pyridinium 
porphyrins 6b and 6c. 
imidazole (0.64g, 9.42 mmol), and I2 (1.59g, 6.28 mmol) in 60ml of 
toluene was heated to reflux and stirred at this temperature for 4 h, at 
which point the solids had completely dissolved and TLC analysis 
showed no remaining starting material. The mixture was allowed to cool 
to room temperature; then 100 ml of saturated aqueous NaHCO, was 
added and the mixture was stirred for 5 min. I2 was then added in small 
portions with vigorous stirring until the organic phase remained iodine- 
colored. Excess I2 was then destroyed by addition of 1 M Na,S,O, 
with stirring; then the mixture was transferred to a separatory funnel 
and diluted with 50 ml of toluene. The phases were separated and the 
organic phase was washed with 50 ml of water, dried (MgSO,) and 
concentrated by rotary evaporation. The residue was purified by flash 
chromatography, eluting with 4:l CH,CI,-acetone, to yield 1.08g 
(80%) of the title compound as a pale yellow oil. ‘H NMR (CDC13) 
63.76 (t, J=6.7, 2H), 3.63-3.69 (m, 6H), 3.59 (dd, J=3.4, 5.5, 2H), 
3.26 (t, J=7.0, 2H), 1.58 (quintet, J=6.7, 2H), 1.21-1.36 (m, 20H), 
0.88 (t, J=6.7, 3H); 13C NMR (CDCI,) 6 72.0, 71.5, 70.7, 70.6, 70.2, 
70.0, 31.9, 29.6, 29.5, 29.3, 26.1, 22.6, 14.1, 2.8; FAB MS (M + 1) 
m/e calculated for C,,H,,O,I 429, found 429. 
1 ‘-~2-~2-(2-{2-~2-(2-idoethoxy)ethoxy~ethoxy)ethoxy)efhoxy~e~hoxy)do- 
decane (4b). Prepared from polyoxyethylene 6-lauryl ether (3b), as 
described above, in 86% yield. IH NMR (CDCI,) 6 3.75 (t, J=6.7, 2H), 
3.61-3.71 (m, 16H), 3.57 (dd, J=3.4, 5.2, 2H), 3.44 (t, J=7.0, 2H), 
3.26 (t, J= 7.0, 2H), 1.58 (br quintet, J= 7.0, 2H), 1.25 (br s, 20H), 0.87 
(br t, J=7.3, 3H); 13C NMR (CDCI,) 6 71.9, 71.5, 70.5, 70.2, 70.0, 
31.8, 29.6, 29.4, 29.3, 26.0, 22.6, 14.1, 2.8); HRMS (M+ 1) m/e calcu- 
lated for C,,H,,O,I 561.2594, found 561.2661. 
l’-(2-[22-(2-iodoethoxy)ethoxy]efhoxy)dodecane (4a). A suspension of H,AmPEGTPyf (6bl. To a suspension of TPyP (300 mg, 0.48 mmol) 
polyoxyethylene 3-lauryl ether 3a (1’~(2-[2-(2-hydroxyethoxy)ethoxy] in 110 ml dimethyl formamide (DMF) was added l’-{2-[2-(2. 
ethoxy}dodecane, 1 .OO g, 3.14 mmol), Ph,P (2.47 g, 9.42 mmol), iodoethoxy)ethoxyIethoxy)dodecane 4a (3.0 g, 7.00 mmol) in 10 ml of 
Table 2 
Electrospray mass spectrometry data for cationic porphyrins 6a-c 
Porphyrin Formula MW ml2 Calc’d Obs’d 
6a 
6c 
1295 ml4 
m-H+/3 
m-R,+/3 
m-H+-R,+/2 
m-2R,+/2 
m-3R,+ll 
1825 ml4 
m-H+/3 
m-R2+/3 
m-H+-R2+/2 
m-2R,+/2 
m-3R,+ll 
ml4 
m-H+/3 
m-R,+13 
m-H+-R,+12 
m-2R3+/2 
m-3R,+/l 
2352 
324 324 
432 432 
562 562 
479 479 
787 787 
375 375 
456 456 
608 608 
508 508 
761 761 
611 611 
920 920 
588 588 
784 784 
639 fg@ 
959 959 
743 743 
1052 1052 
Formulas and MWs are calculated without the counter ions. R, represents the dodecyl sidechain of porphyrin 6a (C,,H,,); R, represents the 
PEG3-dodecyl sidechain of porphyrin 6b (C,,H,,O,); R, represents the PEGG-dodecyl sidechain of porphyrin 6c (C,,H,,O,). For each 
compound, the most abundant peak is underlined. 
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DMF. The mixture was heated to reflux (at which point all solids were 
dissolved) and stirred at this temperature overnight (22 h). The mixture 
was allowed to cool to -40°C; then DMF was removed by vacuum dis- 
tillation at 40-60°C. The remaining red-brown slurry was applied to a 
Sephadex LH-20 column (5 x 40 cm), eluting with MeOH, and collect- 
ing only the red-brown porphyrin band. This fraction was resubjected to 
chromatography on a second Sephadex LH-20 column (5 x 25 cm), 
retaining only the fractions in which the UV-visible spectrum showed 
no extraneous peaks and the Soret maximum of the porphyrin was at 
424-426 nm, to yield 1.05 g (94%) of the title compound as a shiny 
purple solid. ‘H NMR (DMSO-d6, 150°C) 6 9.44-9.58 (m, 8H), 
8.88-9.15 (m, 8H), 8.19-8.23 (m, 8H), 5.18-5.26 (m, 8H), 4.30-4.40 
(m, 8H), 3.80-3.90 (m, 8H), 3.48-3.76 (m, 24H), 3.32-3.46 (m, 8H), 
0.98-l .72 (m, 80H), 0.78-0.92 (m, 12H), -2.75 (br s, 2H). UV-visible 
(50 mM phosphate buffer pH 7.4) A,,= 424 nm, log E= 5.35. 
HpAmTPyP (6a). IH NMR (DMSO-d6, 150°C) 6 9.56 (d, J = 6.8, 8H), 
9.15 (s, 16H), 8.97 (d, J=6.4, 8H), 5.03 (t, f= 7.32, 8H), 2.39 (app 
quintet, J= 7.3, 8H), 1.68 (app quintet, J= 7.3, 8H), 1.57 (app quintet, 
J=6.8, 8H), 1.46-1.24 (m, 56H), 0.90 (br t, J=6.8, 12H); -2.80 (br 
s, 1.6H). Anal. Calculated for CssH,,,N,I,: C, 58.60; H, 7.05; N, 6.21. 
Found C, 58.31; H, 7.15; N, 5.94. UV-visible (50 mM phosphate 
buffer pH 7.4) A,,= 432 nm, log E= 5.35. 
HzAmPEG6TPyP (6~). ‘H NMR (DMSO-d6, 150°C) 6 9.42-9.56 (m, 
8H), 8.84-9.18 (m, 8H), 8.16-8.28 (m, 8H), 5.14-5.26 (m, 8H), 
4.24-4.40 (m, 8H), 3.20-3.90 (m, 88H), 1 .OO-1.60 (m, 80H), 
0.75-0.90 (br s, 12H), -2.35 (br s, 1.8H). UV-visible (50 mM phos- 
phate buffer pH 7.4) h,,, = 422 nm, log E= 5.34. 
Mefalloporphyrins la-c and 2a-c. The metalloporphyrins were pre- 
pared by standard methods [53] from the corresponding free-base por- 
phyrins 6a-c, and were used without further purification. Compounds 
1 a-c showed UV-visible spectra characteristic of iron porphyrins (1 a, 
h,,=438, log &=4.79; lb, h,,=422, log &=4.81; lc, h,,=418, 
log E = 4.78), and compounds 2a-c showed UV-visible spectra char- 
acteristic of manganese porphyrins (2a, I,,,= 468, log s=4.96; 2b, 
h,, = 466, log E= 4.96; 2c, h,,= 464, log E = 4.96). 
Synthesis of ONOO- 
We prepared ONOO- according to the method of Hughes and Nicklin 
[73], as follows. Solutions of NaNO, (0.6 M), H,O, (0.6 M) acidified by 
HCI (0.7 M), and NaOH (0.6 M) were cooled in an ice bath for 
15-30 min. The NaNO, solution (10 ml) was stirred rapidly in an ice 
bath, and to this solution was added the acidified H,O, solution 
(10 ml), followed in rapid succession by the NaOH solution (10 ml). 
The formation of an intensely yellow solution confirmed the successful 
oxidation of NaNO,; this yellow solution rapidly decomposed to a col- 
orless solution in the absence of added base. Yields were maximized 
by precisely timing the addition of the NaOH solution, which deproto- 
nates the unstable HOONO to produce the stable ONOO-. The con- 
centration of ONOO- was determined by measuring the UV 
absorbance of the solution at 302 nm (s= 1670+50 M cm-l); typical 
yields were 55-60%. The ONOO- solutions were stored at -20°C for 
up to one month, and concentrations were measured immediately prior 
to using the solutions. Solutions with ONOO- concentrations lower 
than -80 mM were discarded. 
Preparation of vesicles 
Small unilamellar DMPC vesicles were prepared as follows: 10 pmol of 
DMPC plus the required amphiphilic porphyrin (various concentra- 
tions), and, if necessary, tocopherol (0.5 pmol), were dissolved in a 
small amount of chloroform in a 5-ml test tube. The chloroform was 
evaporated under a gentle stream of argon to form a thin film, and the 
film was dried for at least 3 h, and up to overnight, under vacuum. Then 
3 ml of 50 mM phosphate buffer (pH 7.4) was added, and the mixture 
was sonicated for 10 min in a water bath (22-24°C) using a probe-tip 
sonicator, at which point the solution appeared transparent. The vesic- 
ular solution was allowed to equilibrate for 30 min, then centrifuged at 
12,000 r.p.m. for 10 min to remove titanium dust and other particulate 
matter. Sterically stabilized liposomes were similarly prepared from 
chloroform solutions containing 10 pmol DMPC, 5 kmol cholesterol 
and 0.8pmol PEG-2000~DSPE, plus the required amphiphilic por- 
phyrin, and, if necessary, tocopherol (0.5 umol). To confirm binding of 
the porphyrins to the vesicles, we performed size exclusion chromatog- 
raphy on Sepharose 4B of a vesicular suspension of porphyrin 1 b. 
Analysis of the eluting fractions by UV-visible absorbance spec- 
troscopy showed that the porphyrin (424 nm) eluted with the lipid frac- 
tion (300 nm). Suspensions of DMPC vesicles incorporating the 
PEG-3 porphyrins 1 b and 2b remained visually transparent and did not 
show increased scattering in the UV-visible spectra for a period of at 
least 12 h. Suspensions of DMPC vesicles incorporating the PEG-6 
porphyrins lc and 2c begain to show increased scattering in the 
UV-visible spectra after -2 h, and began to appear visually cloudy, 
indicating significant aggregation after -3-4 h. Finally, suspensions of 
sterically stabilized vesicles incorporating 1 b and 2b remained visually 
clear for a period of more than six months. 
Reaction kinefics 
Reaction kinetic profiles were collected on a HI-TECH SF-61 DX2 
stopped-flow spectrophotometer in the photomultiplier mode, using 
single-mixing. ONOO- was monitored at 302 nm, and Mn(lll) and 
oxoMn(lV) species were monitored at 462 and 428 nm, respectively. 
All reactions were conducted in phosphate pH 7.4 buffer, at a final 
buffer concentration of 25 mM, and at ambient temperature 
(22-24’C). Nonlinear least-squares fitting of the data was performed 
either by using the software supplied by HI-TECH or by importing the 
data into Kaleidagraph 3.0 for fitting. 
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